Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Journal of Women'S Health (2002)
|
April 19, 2007
Health hazards in middle-aged women with cardiovascular disease: a case-control study of swedish women. the women's health in the Lund area (WHILA) study
Yasameen A Shakir, Göran Samsioe, Ali Khatibi E, et al.
Metabolism: Clinical and Experimental
|
February 4, 2005
Albuminuria and hypertension are independently associated with circulating antipericyte autoantibodies in type 2 diabetic patients
Ramesh C Nayak, Elizabet Agardh, Michael G K Kwok, et al.
International Journal of Molecular Medicine
|
June 2, 2010
Evaluation of the aldose reductase inhibitor fidarestat on ischemia-reperfusion injury in rat retina
Irina G Obrosova, Yury Maksimchyk, Pal Pacher, et al.
BMC Medicine
|
August 8, 2015
Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy
Elisabet Agardh, Annika Lundstig, Alexander Perfilyev, et al.
Diabetes Research and Clinical Practice
|
November 23, 2011
HLA-DQB1 genotypes and islet cell autoantibodies against GAD65 and IA-2 in relation to development of diabetes post partum in women with gestational diabetes mellitus
Anastasia Papadopoulou, Kristian F Lynch, Eva Anderberg, et al.
Acta Ophthalmologica
|
July 18, 2008
Increased retinopathy occurrence in type 1 diabetes patients with increased serum levels of the advanced glycation endproduct hydroimidazolone
Dag S Fosmark, Jens P Berg, Aase-Brith Jensen, et al.
Retina (Philadelphia, Pa.)
|
February 10, 2007
Circulating antipericyte autoantibodies: a novel modifier of risk of progression of diabetic retinopathy?
Ramesh C Nayak, Kristian Lynch, Carin Gustavsson, et al.
Metabolism: Clinical and Experimental
|
January 21, 2006
Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus
Dag Sigurd Fosmark, Peter A Torjesen, Bente K Kilhovd, et al.
Journal of Diabetes and Its Complications
|
July 5, 2005
Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes
Carl-David Agardh, Corrado M Cilio, AsaLinda Lethagen, et al.
Acta Ophthalmologica
|
January 22, 2015
Photocoagulation of human retinal pigment epithelium in vitro: unravelling the effects on ARPE-19 by transcriptomics and proteomics
Poya Tababat-Khani, Carolina de la Torre, Francesc Canals, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Journal of Women'S Health (2002)
|
April 19, 2007
Health hazards in middle-aged women with cardiovascular disease: a case-control study of swedish women. the women's health in the Lund area (WHILA) study
Yasameen A Shakir, Göran Samsioe, Ali Khatibi E, et al.
Metabolism: Clinical and Experimental
|
February 4, 2005
Albuminuria and hypertension are independently associated with circulating antipericyte autoantibodies in type 2 diabetic patients
Ramesh C Nayak, Elizabet Agardh, Michael G K Kwok, et al.
International Journal of Molecular Medicine
|
June 2, 2010
Evaluation of the aldose reductase inhibitor fidarestat on ischemia-reperfusion injury in rat retina
Irina G Obrosova, Yury Maksimchyk, Pal Pacher, et al.
BMC Medicine
|
August 8, 2015
Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy
Elisabet Agardh, Annika Lundstig, Alexander Perfilyev, et al.
Diabetes Research and Clinical Practice
|
November 23, 2011
HLA-DQB1 genotypes and islet cell autoantibodies against GAD65 and IA-2 in relation to development of diabetes post partum in women with gestational diabetes mellitus
Anastasia Papadopoulou, Kristian F Lynch, Eva Anderberg, et al.
Acta Ophthalmologica
|
July 18, 2008
Increased retinopathy occurrence in type 1 diabetes patients with increased serum levels of the advanced glycation endproduct hydroimidazolone
Dag S Fosmark, Jens P Berg, Aase-Brith Jensen, et al.
Retina (Philadelphia, Pa.)
|
February 10, 2007
Circulating antipericyte autoantibodies: a novel modifier of risk of progression of diabetic retinopathy?
Ramesh C Nayak, Kristian Lynch, Carin Gustavsson, et al.
Metabolism: Clinical and Experimental
|
January 21, 2006
Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus
Dag Sigurd Fosmark, Peter A Torjesen, Bente K Kilhovd, et al.
Journal of Diabetes and Its Complications
|
July 5, 2005
Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes
Carl-David Agardh, Corrado M Cilio, AsaLinda Lethagen, et al.
Acta Ophthalmologica
|
January 22, 2015
Photocoagulation of human retinal pigment epithelium in vitro: unravelling the effects on ARPE-19 by transcriptomics and proteomics
Poya Tababat-Khani, Carolina de la Torre, Francesc Canals, et al.
Page
of 6